循环B淋巴细胞中雷诺丁受体钙漏作为心力衰竭生物标志物
该研究探讨循环B淋巴细胞中RyR1介导的钙漏作为心力衰竭生物标志物的潜力。研究对比了心衰患者、左心室辅助装置植入后患者及对照者的血液,以及缺血性心衰小鼠和S107治疗小鼠。结果显示心衰时B淋巴细胞RyR1重构、内质网钙储备减少,钙漏与循环儿茶酚胺水平相关,S107可减少钙漏,提示该钙漏可反映细胞内钙处理及交感负荷。
要点
- 心衰患者和小鼠的循环B淋巴细胞显示RyR1重构和内质网钙储备减少,提示慢性细胞内钙漏。
- B淋巴细胞钙漏与循环儿茶酚胺水平相关,并可被Rycal S107显著减少。
- 流式细胞术评估的B淋巴细胞RyR1钙漏可作为监测心衰药物和机械治疗反应的生物标志物。
核心结论
- 心衰时B淋巴细胞表现重构的漏钙RyR1通道和内质网钙储备减少,与慢性细胞内钙漏一致。
- 流式细胞术评估的B淋巴细胞RyR1钙漏提供细胞内钙处理和全身交感负荷的替代指标,是监测药物和机械心衰治疗反应的新生物标志物。
研究设计与样本
- 采集心衰患者、左心室辅助装置植入后心衰患者及对照者的全血,以及缺血性心衰小鼠、缺血性心衰+S107治疗小鼠和野生型对照小鼠的血液。
- 通过免疫沉淀RyR1后免疫染色评估通道大分子复合物,用流式细胞术测量B淋巴细胞在内质网RyR1激动剂存在与否时的钙荧光以评估RyR1钙漏。
主要发现
- 人心衰和鼠心衰的循环B淋巴细胞显示RyR1重构和内质网钙储备减少,与慢性细胞内钙漏一致。
- 该钙漏与循环儿茶酚胺水平相关。
- S107治疗小鼠的细胞内钙漏显著减少。
- 左心室辅助装置治疗的心衰患者呈现异质性反应。
临床怎么用
- B淋巴细胞RyR1钙漏或可作为心衰患者细胞内钙处理异常和交感负荷的替代生物标志物。
- 该指标有潜力用于监测心衰对药物治疗和机械循环支持的反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Advances in congestive heart failure (CHF) management depend on biomarkers for monitoring disease progression and therapeutic response. During systole, intracellular Ca2+ is released from the sarcoplasmic reticulum into the cytoplasm through type-2 ryanodine receptor/Ca2+ release channels. In CHF, chronically elevated circulating catecholamine levels cause pathological remodeling of type-2 ryanodine receptor/Ca2+ release channels resulting in diastolic sarcoplasmic reticulum Ca2+ leak and decreased myocardial contractility. Similarly, skeletal muscle contraction requires sarcoplasmic reticulum Ca2+ release through type-1 ryanodine receptors (RyR1), and chronically elevated catecholamine levels in CHF cause RyR1-mediated sarcoplasmic reticulum Ca2+ leak, contributing to myopathy and weakness. Circulating B-lymphocytes express RyR1 and catecholamine-responsive signaling cascades, making them a potential surrogate for defects in intracellular Ca2+ handling because of leaky RyR channels in CHF. METHODS: Whole blood was collected from patients with CHF, CHF following left-ventricular assist device implant, and controls. Blood was also collected from mice with ischemic CHF, ischemic CHF+S107 (a drug that specifically reduces RyR channel Ca2+ leak), and wild-type controls. Channel macromolecular complex was assessed by immunostaining RyR1 immunoprecipitated from lymphocyte-enriched preparations. RyR1 Ca2+ leak was assessed using flow cytometry to measure Ca2+ fluorescence in B-lymphocytes in the absence and presence of RyR1 agonists that empty RyR1 Ca2+ stores within the endoplasmic reticulum. RESULTS: Circulating B-lymphocytes from humans and mice with CHF exhibited remodeled RyR1 and decreased endoplasmic reticulum Ca2+ stores, consistent with chronic intracellular Ca2+ leak. This Ca2+ leak correlated with circulating catecholamine levels. The intracellular Ca2+ leak was significantly reduced in mice treated with the Rycal S107. Patients with CHF treated with left-ventricular assist devices exhibited a heterogeneous response. CONCLUSIONS: In CHF, B-lymphocytes exhibit remodeled leaky RyR1 channels and decreased endoplasmic reticulum Ca2+ stores consistent with chronic intracellular Ca2+ leak. RyR1-mediated Ca2+ leak in B-lymphocytes assessed using flow cytometry provides a surrogate measure of intracellular Ca2+ handling and systemic sympathetic burden, presenting a novel biomarker for monitoring response to pharmacological and mechanical CHF therapy.
引用
- Kushnir A, Santulli G, Reiken SR, et al. Ryanodine Receptor Calcium Leak in Circulating B-Lymphocytes as a Biomarker in Heart Failure. Circulation. 2018. PMID: 29593014. doi:10.1161/CIRCULATIONAHA.117.032703
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。